Arthritis, a new adverse effect of anti-IL5 biologics in severe asthma patients?
C. Dupin (Paris, France), L. Morer (Paris, France), M. Phillips-Houlbracq (Paris, France), L. Deneuville (Paris, France), M. Lebrun (Paris, France), L. Tabeze (Paris, France), P. Juge (Paris, France), C. Taille (Paris, France)
Source: International Congress 2022 – Studies targeting IL-5 pathways in asthma
Session: Studies targeting IL-5 pathways in asthma
Session type: Thematic Poster
Number: 2127
 
Rating: 
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
C. Dupin (Paris, France), L. Morer (Paris, France), M. Phillips-Houlbracq (Paris, France), L. Deneuville (Paris, France), M. Lebrun (Paris, France), L. Tabeze (Paris, France), P. Juge (Paris, France), C. Taille (Paris, France). Arthritis, a new adverse effect of anti-IL5 biologics in severe asthma patients?. 2127
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
|
|